Public health agency the US Food and Drug Administration announced on Friday that it has approved the marketing of the first duodenoscope in the US with a sterile, disposable elevator component that will reduce the number of parts that need to be cleaned and disinfected in between uses under its premarket clearance (510(k)) pathway.
The FDA reportedly granted clearance of the ED34-i10T2 to Pentax of America.
Additionally, the agency stated the Pentax Medical Video ED34-i10T2 model duodenoscope is intended to to be used with endoscopic devices and provide visualization and access to the upper gastrointestinal (GI) tract to treat bile duct disorders and other upper GI problems. The first duodenoscope with disposable elevator piece reduces the number of parts needing disinfection.
In August, the FDA released a safety communication recommending that duodenoscope manufacturers and health care facilities transition to duodenoscopes with disposable components. Disposable designs can simplify or eliminate the need for reprocessing of certain components, which may reduce between-patient duodenoscope contamination.
This FDA clearance is the first duodenoscope device with a disposable elevator component -- a part that has been traditionally difficult to clean and reprocess.
Saluda Medical secures CE certification for EVA Sensing Technology in Europe
Antin to acquire clinical trial equipment provider Emsere
Hyphens Pharma licenses Cerapro skin cream to Louis Widmer for six European markets
Profusa signs French distributor to expand Lumee Oxygen rollout in Europe
Sensiva Health names new chief operating officer
BrioHealth Solutions enrols 100th participant in BrioVAD System trial
Abbott's Amplatzer Piccolo Delivery System receives US FDA clearance and CE Mark
Amphix Bio announces initial closing of USD12.5m seed financing round
Bioretec wins FDA breakthrough status for biodegradable orthopaedic DrillPin
Amferia raises EUR3.5m to advance antimicrobial wound-care platform
BioCryst wins FDA approval for oral HAE prophylaxis in young children
ALR Technologies announces GluCurve Pet CGM relaunch in Canada
Galderma secures EU MDR certification for Sculptra, expanding use to multiple body areas
Clinical Laserthermia Systems applies for CE marking of ClearPoint Prism neuro laser system